With almost 20 years’ experience, Liz is a sought after adviser for pharmaceutical, biotech and medical devices companies alike and has represented companies in the life sciences industry in patent matters in the English Courts all the way up to the Supreme Court. Her extensive experience of coordinating cross-border litigation within Europe and beyond means that her strategic advice is particularly valued making her a trusted commercial adviser to her many clients.
Liz is a qualified solicitor advocate, a qualification she has used successfully to obtain an interim injunction on short notice in the High Court.
Liz’s background in natural sciences provides her with an excellent understanding of the technical and commercial issues facing those operating in the life sciences industry. Liz regularly advises clients on the implications of the proposed Unitary Patent and the Unified Patent Court and played an integral part in representing the alleged infringer in the much publicised Bristows UPC real-time mock action.
Liz’s work is regularly published in industry journals. She is also a member of EPLAW, EPLIT, and CIPA, and sits on the CIPA Life Sciences Committee.
She is frequently asked to comment and lecture on legal issues affecting the life sciences sector and she is a regular speaker at international conferences on strategic considerations for European and international patent litigation. Liz is a tutor on the Oxford University Diploma in Intellectual Property law and Practice course, teaching patent litigation.
- MA Natural Sciences, University of Cambridge
- Diploma in Intellectual Property Law and Practice, University of Bristol
- Solicitor Advocate 2005
- Qualified 2001
- Partner 2008
- Joint Managing Partner 2017
What others say
"Liz Cohen is joint head of life sciences and is frequently called upon by medical device and pharmaceutical manufacturers to handle complex patent litigation, often across jurisdictions. An area of recent focus has been spearheading the firm's advisory services on the implications of the proposed Unitary Patent and the Unified Patent Court."Chambers and Partners 2019
"Liz Cohen concentrates on life sciences patent disputes, often cases spanning multiple jurisdictions. She has litigated before courts at all levels, including the UK Supreme Court."Chambers and Partners 2019
"The hard graft that Liz Cohen puts in pre-trial is reflected in a sublime track record; she has made a name for herself at courts across the land."IAM Patent 1000 2018
Liz Cohen is "a brilliant lawyer and a leader in her field" according to respondents who appreciate her impeccable understanding of the technical and commercial issues faced by her clients.Who's Who Legal 2018
Liz Cohen advises life sciences companies on multi-jurisdictional patent litigation. Sources say: "She is just fantastic with clients, very good at explaining things in a way they understand and very calm under pressure."Chambers and Partners 2018
Liz Cohen manages complex, cross-border patent litigation for medical device and pharmaceutical manufacturers. "She is just fantastic with clients and very calm under pressure," according to commentators.Chambers and Partners 2018
“Liz Cohen is a noted patent litigator and adviser on the implications of the forthcoming European Unified Patent Court. Sources say: ‘She is a great leader, has loads of patent litigation experience and is charming to boot’.”Chambers and Partners 2017
"Liz Cohen is a patent litigator recognised for her focus on life sciences. Clients say: ‘Her technical ability is very strong and her calmness under pressure is very reassuring’."Chambers and Partners 2017
"Liz Cohen recently represented biosimilar manufacturer Celltrion in a revocation action – only the second time that a patent case relating to a biosimilar has been brought to trial in the United Kingdom."IAM Patent 1000 2017
"Liz is a tenacious lawyer.”Managing Intellectual Property, IP Stars 2016
"Liz Cohen played a key role in the Smith and Nephew matter; with a background in natural sciences, she has lately been advising clients on the implications of the UPC.”IAM Patent 1000 2016
Best Lawyers™ in the United Kingdom for Intellectual Property Law
Intellectual Property: Patent Litigation
Chambers and Partners 2019/2018
Life Sciences: IP/Patent Litigation
Chambers and Partners 2019
Patent Litigation and The Top 250 Women in IP
Managing Intellectual Property, IP Stars 2019/2018
Pharmaceuticals and Biotechnology
Legal 500 2019/2018
Patents, Litigation and Life Sciences, Patent Litigation
Who’s Who Legal 2019/2018
Expert Guides: Women in Business Law 2018
IAM Patent 1000 2018
Legal 500 2017
Who’s Who Legal Thought Leader 2017
6th and 4th Edition of Best Lawyers™ in the United Kingdom for Intellectual Property Law